News | May 06, 2011

African Americans Experience Worse Long-Term Outcomes After PCI

May 6, 2011 – African American patients who undergo angioplasty and stenting fare worse over the long run than patients of other races, regardless of socioeconomic status. In fact, the risk of dying within about three years is more than twice as high among African Americans, according to a study presented today at the Society for Cardiovascular Angiography and Interventions (SCAI) 2011 Scientific Sessions.

“We need to channel healthcare resources to effectively treat this vulnerable population,” said Steve Attanasio, D.O., an interventional cardiology fellow at Rush University Medical Center in Chicago. “It’s very worrisome that the first major cardiac problem many of these patients experience following coronary intervention is death.”

The study focused on 1,432 consecutive patients who had percutaneous coronary intervention (PCI) at John H. Stroger, Jr. Hospital of Cook County in Chicago and received follow-up within the same public health system. The patients were relatively young (57-years-old on average). They were also relatively high-risk: Only about 30 percent had a pre-scheduled procedure for stable coronary disease, while the remaining 70 percent needed urgent PCI because of a heart attack or unstable chest pain.

After an average follow-up of 2.7 years, the combined rate of survival without heart attack or need for a repeat procedure in the treated artery was 78 percent among African American patients, as compared with 86 percent among patients of another race (p=0.001). The overall death rate at 2.7 years was 8.6 percent; however, among African Americans, it spiked to 12.1 percent, as compared with 5 percent among other patients (p

The reason for the increased risk among African Americans is not yet known, though many things may play a role, including poorly understood genetic and sociocultural factors. But the importance of aggressively treating risk factors such as diabetes, high blood pressure, high cholesterol and smoking is clear, as is the need to educate patients about a heart-healthy lifestyle.

“The ultimate goal is prevention,” Attanasio said. “We need to reach out not only to patients but also to healthcare providers. It’s not enough to perform a stenting procedure. These patients require close follow-up.”

This study received no outside funding.

For more information: www.scai.org, www.SecondsCount.org

Related Content

A key slide from Elnabawi's presentation, showing cardiac CT plaque evaluations, showing the impact of psoriasis medication on coronary plaques at baseline and one year of treatment. It shows a reversal of vulnerable plaque development. #SCAI, #SCAI2018

A key slide from Elnabawi's presentation, showing cardiac CT plaque evaluations, showing the impact of psoriasis medication on coronary plaques at baseline and one year of treatment. It shows a reversal of vulnerable plaque development.  

Feature | Cardiovascular Clinical Studies | May 14, 2018
May 14, 2018 – New clinical evidance shows common therapy options for psoriasis (PSO), a chronic inflammatory skin di
Intravenous Drug Use is Causing Rise in Heart Valve Infections, Healthcare Costs. #SCAI, #SCAI2018
News | Cardiovascular Clinical Studies | May 14, 2018
May 14, 2018 — The opioid drug epidemic is impacting cardiology, with a new study finding the number of patients hosp
Patient Enrollment Completed in U.S. IDE Study of THERMOCOOL SMARTTOUCH SF Catheter
News | Cardiovascular Clinical Studies | March 15, 2018
March 15, 2018 –  Johnson & Johnson Medical Devices Companies announced today that Biosense Webster, Inc., who wo
Lexington Begins HeartSentry Clinical Trial
News | Cardiovascular Clinical Studies | February 20, 2018
February 20, 2018 – Lexington Biosciences, Inc., a development-stage medical device company, announced the commenceme
Endologix Completes Patient Enrollment in the ELEVATE IDE Clinical Study
News | Cardiovascular Clinical Studies | February 06, 2018
February 6, 2018 – Endologix, a developer and marketer of treatments for aortic disorders, announced the completion o
12-Month Results from Veryan Medical's MIMICS-2 IDE Study Presented at LINC
News | Cardiovascular Clinical Studies | February 01, 2018
February 1, 2018 – Thomas Zeller (Bad Krozingen, Germany) presented the 12-month results from Veryan Medical’s MIMICS
LimFlow Completes U.S. Feasibility Study Enrollment, Receives FDA Device Status
News | Cardiovascular Clinical Studies | February 01, 2018
February 1, 2018 –  LimFlow SA, developer of minimally-inv
ESC 2017 late breaking trial hot line study presentations.
News | Cardiovascular Clinical Studies | September 12, 2017
September 12, 2017 – The European Society of Cardiology (ESC) Congress 2017 includes several Hot Line Late-breaking C
U.K., NHS studies, weekend effect, hospital admission, atrial fibrillation, heart failure
News | Cardiovascular Clinical Studies | June 28, 2016
New research shows patients admitted to National Health Service (NHS) hospitals in the United Kingdom for atrial...
stroke risk
News | Cardiovascular Clinical Studies | August 28, 2015
Most people assume strokes only happen to octogenarians, but recent evidence suggests that survivors of childhood can
Overlay Init